Drug Trial Radar · NCT03678129
GABA Pathways in Autism Spectrum Disorder (ASD)
Last checked: Nov 19, 2026Latest source record: Aug 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
109
Actual
Start
Dec 7, 2018
Primary completion
Jun 27, 2025
Study completion Jun 27, 2025
Sponsor
- Lead sponsor
- King's College LondonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 19, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study investigates the brain response to a single acute dose of a GABAa receptor acting drug (Benzodiazepine or positive allosteric modulator) compared to a single dose of placebo in adults with and without autism spectrum disorder.
Conditions
- Autism Spectrum Disorder
Interventions
AZD7325_10Drug
Single oral dose (10mg)
AZD7325_20Drug
Single oral dose (20mg)
PlaceboDrug
Single oral dose placebo (capsule)
ClobazamDrug
Single dose (5mg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Brain activation and connectivity response to GABAergic stimulation as assessed by functional magnetic resonance imaging.Time frame: Data collected on up to 3 visit days per participant. Completed within up to 1 year.
- Brain electrophysiological activity task-free electroencephalography (EEG)Time frame: Data collected on up to 3 visit days per participant. Completed within up to 1 year
- Brain oscillations under sensory stimulationTime frame: Data collected on up to 3 visit days per participant. Completed within up to 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
King's College London
London, London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.